Katja Römer

734 total citations
6 papers, 405 citations indexed

About

Katja Römer is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Katja Römer has authored 6 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Katja Römer's work include HIV Research and Treatment (3 papers), HIV-related health complications and treatments (3 papers) and HIV/AIDS drug development and treatment (2 papers). Katja Römer is often cited by papers focused on HIV Research and Treatment (3 papers), HIV-related health complications and treatments (3 papers) and HIV/AIDS drug development and treatment (2 papers). Katja Römer collaborates with scholars based in Germany, United Kingdom and Australia. Katja Römer's co-authors include Bernd Salzberger, Achim Schwenk, Gisela Kremer, M. Elia, Markus Bickel, Christoph D. Spinner, Julia Roider, Markus Müller, Nils Postel and Georg Härter and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Clinical Nutrition and AIDS.

In The Last Decade

Katja Römer

5 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katja Römer Germany 4 199 175 83 57 52 6 405
Gisela Kremer Germany 10 299 1.5× 98 0.6× 97 1.2× 8 0.1× 159 3.1× 12 478
Vito Cianci Italy 12 27 0.1× 198 1.1× 19 0.2× 91 1.6× 56 1.1× 33 426
Nishaki Mehta United States 14 19 0.1× 36 0.2× 12 0.1× 21 0.4× 44 0.8× 71 517
Silvia Magnani Italy 15 115 0.6× 159 0.9× 18 0.2× 69 1.2× 13 0.3× 36 951
Rasmus Bo Hasselbalch Denmark 11 20 0.1× 111 0.6× 6 0.1× 18 0.3× 21 0.4× 42 304
Hatice Beyazal Polat Türkiye 6 236 1.2× 55 0.3× 86 1.0× 1 0.0× 157 3.0× 15 399
Nso Nso United States 11 17 0.1× 162 0.9× 7 0.1× 69 1.2× 16 0.3× 62 498
Thierry Hernández‐Gilsoul Mexico 8 21 0.1× 145 0.8× 9 0.1× 69 1.2× 6 0.1× 24 272
Abdul Rauf Pakistan 10 34 0.2× 64 0.4× 3 0.0× 10 0.2× 20 0.4× 54 308
Veraprapas Kittipibul United States 11 6 0.0× 127 0.7× 11 0.1× 43 0.8× 31 0.6× 60 405

Countries citing papers authored by Katja Römer

Since Specialization
Citations

This map shows the geographic impact of Katja Römer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Römer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Römer more than expected).

Fields of papers citing papers by Katja Römer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Römer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Römer. The network helps show where Katja Römer may publish in the future.

Co-authorship network of co-authors of Katja Römer

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Römer. A scholar is included among the top collaborators of Katja Römer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Römer. Katja Römer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Fischer, Julia, Nina Judith Hos, Raja Ganesan, et al.. (2025). Age-Dependent Loss of Sirtuin1 (Sirt1) Correlates with Reduced Autophagy in Type 2 Diabetic Patients (T2DM). Diabetology. 6(6). 45–45.
2.
Härter, Georg, Christoph D. Spinner, Julia Roider, et al.. (2020). COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection. 48(5). 681–686. 152 indexed citations
3.
Manegold, C., N. Thatcher, C. Kortsik, et al.. (2006). Sequencing of single-agent (SA) docetaxel (T) and gemcitabine (G) therapy for patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of three consecutive randomized trials. Journal of Clinical Oncology. 24(18_suppl). 7035–7035. 3 indexed citations
4.
Fätkenheuer, Gerd, et al.. (2001). Pharmacokinetics of amprenavir and lopinavir in combination with nevirapine in highly pretreated HIV-infected patients. AIDS. 15(17). 2334–2335. 10 indexed citations
5.
Schwenk, Achim, et al.. (2000). Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. American Journal of Clinical Nutrition. 72(2). 496–501. 231 indexed citations
6.
Schwenk, Achim, Gisela Kremer, Katja Römer, et al.. (2000). Risk factors for the HIV-associated lipodystrophy syndrome in a cross-sectional single-centre study.. PubMed. 5(10). 443–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026